Literature DB >> 17125710

[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].

Rafael Laredo1, Lorenzo Monserrat, Manuel Hermida-Prieto, Xusto Fernández, Isabel Rodríguez, Laura Cazón, Inés Alvariño, Carlos Dumont, Pablo Piñón, Jesús Peteiro, Beatriz Bouzas, Alfonso Castro-Beiras.   

Abstract

INTRODUCTION AND
OBJECTIVES: To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with hypertrophic cardiomyopathy (HCM) and their families, and to investigate correlations between genotype and phenotype.
METHODS: Single-strand conformation polymorphism analysis and sequencing of fragments with abnormal MYH7 gene mobility were carried out in 128 consecutive index patients with HCM. The phenotypes of patients with and without mutations were compared and the phenotypes of identified families were recorded.
RESULTS: A total of 11 mutations were found in 13 families (10%); 7/11 had been previously described. The I736T mutation was found in three families and the A797T in two. One patient had two mutations (i.e., I736T and R787H). Mutations were more frequent in patients with a family history of sudden death (31%) and in those with severe hypertrophy (39% had a thickness > or = 30 mm). Mutations were found in 29 of 42 members of the 13 families, including six family members (20%) who were healthy carriers and aged < or = 36 years. Sudden death had occurred in eight members of four families: four in two families with the I736T mutation, one in a family with A797T, one in a family with R870H, and two in a family with A901P.
CONCLUSIONS: MYH7 mutations were present in 10% of our families. Mutations were more frequent in patients with a family history of sudden death and in those with severe hypertrophy. Most mutations had been described previously. Some appeared in several families. For some mutations, the correlation between genotype and phenotype was stable, while for others, there were marked differences between the phenotypes of the index patients and their relatives, suggesting the presence of additional genetic factors that have yet to be identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125710     DOI: 10.1157/13093977

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  10 in total

1.  Expression of uncoupling protein 3 in mitochondria protects against stress-induced myocardial injury: a proteomic study.

Authors:  Xinxing Wang; Jingbo Gong; Xiaohua Liu; Rui Zhan; Ruirui Kong; Yun Zhao; Di Wan; Xue Leng; Ming Chen; Lingjia Qian
Journal:  Cell Stress Chaperones       Date:  2010-04-10       Impact factor: 3.667

Review 2.  Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.

Authors:  Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2017-08-24       Impact factor: 5.460

3.  Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.

Authors:  Pradeep Natarajan; Nina B Gold; Alexander G Bick; Heather McLaughlin; Peter Kraft; Heidi L Rehm; Gina M Peloso; James G Wilson; Adolfo Correa; Jonathan G Seidman; Christine E Seidman; Sekar Kathiresan; Robert C Green
Journal:  Sci Transl Med       Date:  2016-11-09       Impact factor: 17.956

4.  The MYH7 p.R787H mutation causes hypertrophic cardiomyopathy in two unrelated families.

Authors:  G Purushotham; K Madhumohan; Mohammad Anwaruddin; Ha Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan; Murali D Bashyam
Journal:  Exp Clin Cardiol       Date:  2010

5.  Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene.

Authors:  Micah Hamady; Massimo Buvoli; Leslie A Leinwand; Rob Knight
Journal:  Int J Cardiol       Date:  2009-01-26       Impact factor: 4.164

6.  Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy.

Authors:  María Isabel Rodríguez-García; Lorenzo Monserrat; Martín Ortiz; Xusto Fernández; Laura Cazón; Lucía Núñez; Roberto Barriales-Villa; Emilia Maneiro; Elena Veira; Alfonso Castro-Beiras; Manuel Hermida-Prieto
Journal:  BMC Med Genet       Date:  2010-04-30       Impact factor: 2.103

7.  Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation.

Authors:  Zeynep H Coban-Akdemir; Wu-Lin Charng; Mahshid Azamian; Ingrid S Paine; Jaya Punetha; Christopher M Grochowski; Tomasz Gambin; Santiago O Valdes; Bryan Cannon; Gladys Zapata; Patricia P Hernandez; Shalini Jhangiani; Harsha Doddapaneni; Jianhong Hu; Fatima Boricha; Donna M Muzny; Eric Boerwinkle; Yaping Yang; Richard A Gibbs; Jennifer E Posey; Xander H T Wehrens; John W Belmont; Jeffrey J Kim; Christina Y Miyake; James R Lupski; Seema R Lalani
Journal:  Am J Med Genet A       Date:  2020-03-31       Impact factor: 2.802

8.  Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study.

Authors:  Cheng Shen; Lei Xu; Xiaoning Sun; Aijun Sun; Junbo Ge
Journal:  Ann Transl Med       Date:  2022-02

9.  Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing.

Authors:  Luis R Lopes; Anna Zekavati; Petros Syrris; Mike Hubank; Claudia Giambartolomei; Chrysoula Dalageorgou; Sharon Jenkins; William McKenna; Vincent Plagnol; Perry M Elliott
Journal:  J Med Genet       Date:  2013-02-08       Impact factor: 6.318

10.  Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.

Authors:  Lu Han; Yang Li; Jason Tchao; Aaron D Kaplan; Bo Lin; You Li; Jocelyn Mich-Basso; Agnieszka Lis; Narmeen Hassan; Barry London; Glenna C L Bett; Kimimasa Tobita; Randall L Rasmusson; Lei Yang
Journal:  Cardiovasc Res       Date:  2014-09-10       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.